ABK Biomedical raises $35 million USD to bring liver cancer treatment to market
Series D funding will support commercialization of Halifax company’s Eye90 microspheres.
Healthtech
Pawsible Ventures looks to sniff out opportunities in pet health
Vancouver-based studio’s inaugural fund is fetching $10 million to help build pet health startups.
BDC Capital’s Cheri Corbett joins Pender Ventures as partner
Calgary-based Corbett joins a month after Isaac Souweine left the fund.
At Elevate, founders call out barriers holding back Canadian healthtech
Entrepreneurs say slow policy and weak procurement limit Canadians’ access to aging and fertility tech.
PhenoTips raises $2 million to expand “genomic health record” platform’s global reach
Startup will expand in Canada and the UK while laying groundwork in the US, Europe, and Middle East.
Felix eyes preventative health market with new “longevity” testing program
Canadian telehealth company expands beyond on-demand prescriptions for stigmatized conditions.
Avitia partners with Genoscience to expand rapid cancer test access in Québec
Montréal startup aims to bring liquid biopsy tests to Quebec patients outside major centres.
FluidAI lands FDA clearance to sell post-surgery monitor in the US
Kitchener-Waterloo healthtech startup eyes Series B to fuel US commercialization.
Variational AI lands “up to” $349 million USD to discover drugs with Merck
Vancouver firm’s AI platform will generate chemical compounds based on Merck’s therapeutic targets.
Tatum Bioscience makes case for scalable cancer vaccine
Study shows Tatum’s treatment “uncloaked” cancer cells and wiped out tumours in mice.
Pender Ventures partner Isaac Souweine leaves VC firm
“Mutual” decision leaves Souweine searching for new opportunities in Canadian tech.
Wittington Ventures hires former MaRS IAF leader Zeeshan Ali as partner
Weston-backed VC adds Ali to help lead its cleantech and healthtech innovation fund.
Elon Musk brings Neuralink brain implants to Toronto in global first
Surgeries were the first the company has tried outside of the US.
Ontario bets on made-in-province healthtech with streamlined Innovation Pathway
Industry leaders say program could be “turning point” for Ontario’s health system.
FDA approval marks “most significant milestone” in Kardium’s history
Burnaby firm gets US green light for innovative system to treat atrial fibrillation.